Older women benefit from continuing regular mammograms

Image courtesy RSNA

CANCER DIGEST – Nov. 24, 2018 – Women 75 and older continue to benefit from mammograms according to a new study that will be presented this week at the Radiological Society of North America annual meeting in Chicago.

In the study, Dr. Stamatia Destounis and colleagues analyzed data from 763,256 screening mammography exams at Elizabeth Wende Breast Care between 2007 and 2017.

Loneliness boosts risk of heart disease and cancer

Image courtesy of ACS

CANCER DIGEST – Nov. 17, 2018 – Joining a book club or bowling league, playing cards with friends or getting involved in a community club is good for you and could reduce your risk of dying from heart disease or cancer. That’s the finding of the Cancer Prevention Study - II that followed more than 580,000 people for 30 years.

The study led by the American Cancer Society’s Kassandra Alcaraz, PhD, MPH, evaluated whether associations of social isolation with all causes of cardiovascular disease and cancer death differed by race and sex. The study appears in the Oct. 2018 issue of the American Journal of Epidemiology.

New combination treatment shows promise for AML

CANCER DIGEST – Nov. 10, 2018 – A combination of a standard chemotherapy and newer immunotherapy has shown promise in treating people with acute myeloid leukemia or AML, one of the most deadly forms of the disease.

Judge rules patent on Zytiga® invalid

CANCER DIGEST – Nov. 4, 2018 – A federal judge in New Jersey has ruled that Johnson & Johnson’s patent for the anti-prostate cancer drug abiraterone is invalid. The decision clears the way for generic versions of the drug, which are under development by a number of pharmaceutical companies.